Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Borosil Scientific
Small Cap•631 Employees•IPO 2024
Current Price
₹102.84
-0.87 (-0.84%)Updated
Valuation vs Sector
P/E Ratio
57.56vs 36.89
P/B Ratio
2.29vs 9.16
Div Yield
0.00%vs 1.61%
Today's Range
₹100.50
₹104.44
₹102.84
52 Week Range
52W Low₹99.53
52W High₹190.79
₹102.84
Downside3.33%
Upside85.52%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹1,050.91 Cr
Market Cap
Total market value of companyP/E Ratio
60.61
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
2.69
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹1.98
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
10.30%
ROCE
Return on Capital Employed. >15% is goodNet Margin
4.10%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
-%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-7.89%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-55.30%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.04
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹45.47
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
67.80%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
3 points- •Borosil Scientific maintains a very healthy financial structure with an exceptionally low debt-to-equity ratio of 0.04, indicating minimal reliance on borrowed capital and strong balance sheet health for future stability.
- •Promoter confidence remains robust, evidenced by a significant promoter holding of 67.8% as of the latest data, suggesting strong alignment between management and shareholder interests in the company's long-term vision.
Weaknesses
6 points- •Borosil Scientific's stock trades at a high P/E ratio of 51.00, suggesting it might be overvalued compared to its current earnings, and significantly higher than some industry peers, potentially limiting future upside.
- •Borosil Scientific experienced a substantial decline in quarterly profit after tax, with a reported -55.30% variation and a net loss of -4.21 in the latest quarter, raising concerns about recent operational profitability.
Opportunities
3 points- •Expansion within the 'Glass - Industrial' sector, driven by increasing demand in manufacturing and infrastructure, presents a significant opportunity for Borosil Scientific to capture a larger market share and boost revenues.
- •Exploring new product lines or innovative applications within the scientific glass domain could unlock new revenue streams and reduce dependency on existing offerings, enhancing market competitiveness and growth.
Threats
4 points- •Intense competition from peers like Sejal Glass and Agarwal Toughened, some exhibiting higher ROCE and lower P/E ratios, poses a threat to market share and pricing power for Borosil Scientific.
- •Fluctuations in raw material prices, particularly for specialized glass components, could significantly impact Borosil Scientific's operating margins and profitability, posing a continuous cost management challenge.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹112.57 | +₹9.73 | +9.46% |
| R3 | ₹108.63 | +₹5.79 | +5.63% |
| R2 | ₹106.53 | +₹3.69 | +3.59% |
| R1 | ₹104.69 | +₹1.85 | +1.80% |
| PIVOT | ₹102.59 | -0.25 | -0.24% |
| CURRENT | ₹102.84 | - | - |
| S1 | ₹92.87 | -₹9.97 | -9.70% |
| S2 | ₹96.81 | -₹6.03 | -5.87% |
| S3 | ₹98.65 | -₹4.19 | -4.07% |
| S4 | ₹100.75 | -₹2.09 | -2.04% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-43.1% vs avg
0.91L
(02 Mar 2026)Delivery %+1.3% vs avg
55.2%
(02 Mar 2026)Avg Volume (20D)20-day average
1.60L
(03 Feb - 02 Mar)Avg Delivery %Trend ↓
53.9%
(03 Feb - 02 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Divis Laboratories Ltd
1.64L ₹ Cr
Best Profit Growth
Brooks Laboratories Ltd
498.00 %
Highest Dividend Yield
Windlas Biotech Ltd
1.29 %
Peer Comparison
| Company Name |
|---|
 Brooks Laboratories Ltd |
 Dishman Carbogen Amcis Ltd |
 Divis Laboratories Ltd |
 |
 Innova Captab Ltd |
 Suven Life Sciences Ltd |
 Tarsons Products Ltd |
 Vimta Labs Ltd |
 Windlas Biotech Ltd |
About
Borosil Scientific Ltd
Borosil Scientific Limited is a prominent manufacturer and supplier of laboratory glassware and related equipment, serving diverse scientific and industrial sectors. Their product portfolio caters to a wide range of applications, solidifying their position as a significant player in the scientific supply chain.
A core component of their business is the production and distribution of laboratory glassware and consumables. This includes a comprehensive selection of items essential for various laboratory procedures, such as beakers, flasks, test tubes, and other specialized glassware. They also provide filtration products and analytical vials, along with a variety of accessories crucial for efficient laboratory operations.
Beyond basic glassware, Borosil Scientific Limited offers a substantial range of laboratory equipment. This equipment caters to various scientific disciplines, including those in nutrition and environmental science, life sciences, and liquid handling. Their offerings extend to encompass advanced instruments and apparatus, supplementing their comprehensive supply of basic laboratory necessities.
The company also plays a significant role in the pharmaceutical industry by manufacturing primary packaging materials. This includes glass ampoules and tubular glass vials, essential for the safe containment and distribution of pharmaceutical products. This segment underscores their commitment to providing solutions across different stages of the pharmaceutical lifecycle.
Further expanding their reach into industrial applications, Borosil Scientific Limited produces process science products. These include lab reactors and industrial reactors, as well as lab and industrial rotary evaporators. These products are critical for research and development, as well as large-scale manufacturing processes in various industries.
In summary, Borosil Scientific Limited's business model encompasses a broad spectrum of laboratory and industrial supplies. Their diverse product portfolio, from basic glassware to advanced process equipment, caters to a wide range of clients across various scientific and industrial sectors. The company's long history, dating back to 1962, speaks to their enduring presence and success in the marketplace.
COMPANY FACTS - BOROSCI
Registered Address
1101, Crescenzo, G-Block, Opp. MCA Club, Bandra Kurla Complex, Bandra ( East)
Mumbai
MAHARASHTRA
IN
Tel: 912267406300
Website:https://www.borosilscientific.com/
Investor Relations:http://www.borosilscientific.com/investor
Company Details
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Life Sciences Tools & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 631
IPO Date: 07/06/2024
MANAGEMENT - BOROSCI
Mr. Kewal Handa
Additional Non-Executive Independent Chairman of the Board
Mr. Vinayak Patankar
Chief Executive Officer, Whole Time Director
Mr. Rajeshkumar Agrawal
Chief Financial Officer
Mr. Sanjay Gupta
Company Secretary, Compliance Officer
Mr. Pradeep Kheruka
Non-Executive Director
Mr. Shreevar Kheruka
Non-Executive Director
Mr. Chandra Mishra
Additional Non-Executive Independent Director
Mrs. Anupa Sahney
Additional Non-Executive Independent Director
Investor Questions Answered
Borosil Scientific Ltd (BOROSCI) Stock FAQs
Get answers to the most common questions about Borosil Scientific Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Borosil Scientific Ltd (BOROSCI) is ₹102.84. Today, the stock has declined by ₹0.87 (0.84%), trading in a range of ₹100.5 to ₹104.44. The stock opened at ₹101 with a trading volume of 91,335 shares.
Borosil Scientific Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,050.91 crores, P/E ratio of 60.61, ROE of 0.00%, and ROCE of 10.30%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Borosil Scientific Ltd (BOROSCI) is ₹190.79, while the 52-week low is ₹99.53. Currently trading at ₹102.84, the stock is 3.6% away from its 52-week low and 46.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Borosil Scientific Ltd stock at ₹102.84 depends on multiple factors. The stock is currently trading with a P/E ratio of 60.61 and P/B ratio of N/A. Today's performance shows a loss of 0.84%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Borosil Scientific Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹102.84, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Borosil Scientific Ltd's key financial metrics include: P/E Ratio: 60.61, P/B Ratio: N/A, ROE: 0.00%, ROCE: 10.30%, Dividend Yield: 0.00%, EPS: ₹1.98, Book Value: ₹45.47, Debt-to-Equity: 0.04, and Current Ratio: N/A. The company's market cap stands at ₹1,050.91 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Borosil Scientific Ltd stock opened at ₹101 and is currently trading at ₹102.84, showing a decline of ₹0.87 (0.84%). The intraday high is ₹104.44 and low is ₹100.5. The trading volume stands at 91,335 shares, indicating moderate market participation today.
Borosil Scientific Ltd has a Price-to-Earnings (P/E) ratio of 60.61, which means investors are willing to pay ₹60.61 for every ₹1 of earnings. With an EPS of ₹1.98, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Borosil Scientific Ltd has a market capitalization of ₹1,050.91 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹102.84) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Borosil Scientific Ltd has a book value of ₹45.47 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹102.84, which is 126.2% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Borosil Scientific Ltd has a Return on Equity (ROE) of 0.00% and Return on Capital Employed (ROCE) of 10.30%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Borosil Scientific Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Borosil Scientific Ltd has a debt-to-equity ratio of 0.04, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Borosil Scientific Ltd has an Earnings Per Share (EPS) of ₹1.98, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹102.84 and P/E ratio of 60.61, investors are paying 60.61 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Borosil Scientific Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Borosil Scientific Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Borosil Scientific Ltd stock, consider: 1) Fundamental Analysis - Review P/E (60.61), ROE (0.00%), debt-to-equity (0.04), and growth rates. 2) Technical Analysis - Check 52-week range (₹99.53 - ₹190.79), moving averages, and chart patterns. 3) Valuation - Compare current price (₹102.84) with book value (₹45.47) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Borosil Scientific Ltd share is ₹1.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹102.84 is 10184x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Borosil Scientific Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹99.53 - ₹190.79). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.04 indicates leverage. 4) Liquidity Risk - Based on trading volume of 91,335 shares. 5) Valuation Risk - P/E of 60.61 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Borosil Scientific Ltd operates in the industry with key metrics: P/E ratio of 60.61, ROE of 0.00%, market cap of ₹1,050.91 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.04), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Borosil Scientific Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹102.84, with a 52-week range of ₹99.53 to ₹190.79. Based on fundamentals like P/E (60.61), ROE (0.00%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Borosil Scientific Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹102.84. 2) Fundamental Deterioration - Declining ROE (currently 0.00%), increasing debt (D/E: 0.04), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Borosil Scientific Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu